直接导航的焦点激光光凝聚器在中央血清性胆红蛋白病变中对胆道神经血管的新血管化进行照射

Dmitrii S Maltsev1, Alexey N Kulikov2, Alexandr S Vasiliev2

  • 1S.M. Kirov Military Medical Academy, Department and Clinic of Ophthalmology, 21 Botkinskaya Str., Saint-Petersburg, Russian Federation. glaz.med@yandex.ru.

PubMed
概括

导航的焦点激光光凝聚 (FLP) 有效地解决了中枢血清性胆红蛋白病变 (CSCR) 和胆道新血管化 (CNV) 的眼睛中的脑下液. 这种安全的治疗选择显示了显著的解剖改善,而没有视力恶化.

相关概念视频

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...